Utama › Penyakit Parkinson › Connecticut › New Haven
Kajian klinikal Penyakit Parkinson di New Haven, CT
14 kajian untuk Penyakit Parkinson sedang mencari peserta di lokasi dalam dan sekitar New Haven (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- XingImaging LLC, New Haven
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Mengambil pesertaFasa 2
- Yale University, New Haven
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Mengambil pesertaFasa 2/3
- Site-028, New Haven
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- Institute for Neurodegenerative Disorders, New Haven
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Mengambil pesertaKajian pemerhatian
- Yale School of Medicine's Stephen and Denise Adams Center for Parkinson's Disease Research, New Haven
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Mengambil pesertaFasa 3
- Institute for Neurodegenerative Disorders, New Haven
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Institute For Neurodegenerative Disorders, New Haven
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Intestinal Immunity in Neurologic Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Yale MS Clinic, North Haven · 7 mi jauh
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Yale New Haven Hospital, New Haven
Imaging Depression in Parkinson's Disease
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- Yale University, New Haven
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
Mengambil pesertaKajian pemerhatian
- Digestive Disease Associates, Branford · 6 mi jauh
Kajian Penyakit Parkinson di bandar lain
- New York City, NY23 kajian
- Boston, MA19 kajian
- Cleveland, OH18 kajian
- Minneapolis, MN17 kajian
- Nashville, TN15 kajian
- Philadelphia, PA14 kajian
- San Francisco, CA14 kajian
- Charleston, SC13 kajian
- Farmington Hills, MI13 kajian
- Chicago, IL13 kajian
- Miami, FL13 kajian
- Aurora, CO12 kajian
Kajian lain di New Haven
- Kanser Paru-paru Bukan Sel Kecil41 kajian
- Kanser Payudara38 kajian
- Kanser (semua jenis)33 kajian
- Kanser Metastatik23 kajian
- Kanser Paru-paru22 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher22 kajian
- Kanser Ovari21 kajian
- Kanser Kolorektal20 kajian
- Kanser Prostat20 kajian
- Leukemia Mieloid Akut17 kajian
- Gangguan Penggunaan Alkohol (AUD)17 kajian
- Dos Berlebihan Opioid17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.